Correspondence 0001683168-24-006427 from CBD Life Sciences Inc. (CBDL)
CBD Life Sciences Inc.
Date: Sept. 16, 2024 · CIK: 0001776073 · Accession: 0001683168-24-006427
AI Filing Summary & Sentiment
File numbers found in text: 024-12430
Letter
VIA EDGAR Office of Life Sciences Division of Corporation Finance Securities and Exchange Commission Re: CBD Life Sciences, Inc. (the “Company”) Post-Qualification Amendment No. 2 to Offering Statement on Form 1-A (the “Offering Statement”) File No. 024-12430
Dear Ms. Gama:
This letter replaces the Company’s request for acceleration submitted earlier today.
On behalf of the Company, I respectfully request that the qualification date of the Offering Statement be accelerated and that the Offering Statement be declared qualified Tuesday, September 17, 2024, at 10:00 a.m. EDT, or as soon thereafter as is reasonably practicable.
In making this request, the Company represents that the Offering Statement will be approved in the State of Colorado, upon qualification by the Securities and Exchange Commission (the “Commission”), and acknowledges the following:
- should the Commission or the Staff, acting pursuant to delegated authority, declare the filing qualified, it does not foreclose the Commission from taking any action with respect to the filing;
- the action of the Commission or the staff, acting pursuant to delegated authority, to declare the filing qualified does not relieve the Company from its full responsibility for the adequacy and accuracy of disclosure in the filing; and
- the Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities law of the United States.
Very truly yours,
/s/ Lisa Nelson
Show Raw Text
CORRESP
1
filename1.htm
CBD LIFE SCIENCES, INC.
10855 N. 116th Street, Suite 115
Scottsdale, Arizona 85259
September 16, 2024
VIA EDGAR
Doris Stacey Gama
Office of Life Sciences
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:
CBD Life Sciences, Inc. (the “Company”)
Post-Qualification Amendment No. 2 to
Offering Statement on Form 1-A (the “Offering Statement”)
File No. 024-12430
Dear Ms. Gama:
This letter replaces the Company’s request for acceleration submitted
earlier today.
On behalf of the Company, I respectfully request
that the qualification date of the Offering Statement be accelerated and that the Offering Statement be declared qualified Tuesday, September
17, 2024, at 10:00 a.m. EDT, or as soon thereafter as is reasonably practicable.
In making this request, the Company represents
that the Offering Statement will be approved in the State of Colorado, upon qualification by the Securities and Exchange Commission (the
“Commission”), and acknowledges the following:
-
should the Commission or the Staff, acting pursuant to delegated authority, declare the filing qualified, it does not foreclose the Commission from taking any action with respect to the filing;
-
the action of the Commission or the staff, acting pursuant to delegated authority, to declare the filing qualified does not relieve the Company from its full responsibility for the adequacy and accuracy of disclosure in the filing; and
-
the Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities law of the United States.
Very truly yours,
/s/ Lisa Nelson
Lisa Nelson
Chief Executive Officer
CDB Life Sciences, Inc.